XNCR · Xencor Inc

$19.97 +0.11 (+0.55%) At close · Jul 28

Market Cap

$1.47B

74.14M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	CEO	$742,800	—	$1,552,892	$2,727,018	$490,248	$8,247	$5,521,205
John Desjarlais	Chief Scientific Officer	$547,900	—	$422,392	$701,368	$301,345	$9,247	$1,982,252
Bart Jan Cornelissen	CFO	$491,600	—	$310,578	$515,712	$243,342	$81,164	$1,642,396
Celia E. Eckert	Senior Vice President, General Counsel and Corporate Secretary	$491,600	—	$310,578	$515,712	$243,342	$9,247	$1,570,479
Nancy Valente	Chief Development Officer	$249,421	—	—	—	—	$181,345	$430,766

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	CEO	$721,200	—	$1,246,193	$4,403,489	$432,700	$8,247	$6,811,829
John Kuch	CFO	$143,591	—	$322,458	$3,181,300	—	$640,179	$4,287,528
Bart Jan Cornelissen	CFO	$338,182	—	$910,811	$2,263,916	$156,938	$61,164	$3,731,011
Nancy Valente	Chief Development Officer	$556,200	—	$448,637	$1,462,211	$278,100	$122,625	$2,867,773
John Desjarlais	Chief Scientific Officer	$534,500	—	$473,543	$1,543,452	$267,250	$9,247	$2,827,992
Celia E. Eckert	Senior Vice President, General Counsel and Corporate Secretary	$475,000	—	$299,084	$974,808	$213,750	$9,247	$1,971,889
General Counsel	—	$475,000	—	$299,084	$974,808	$213,750	$9,247	$1,971,889

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	CEO	$700,200	—	$1,650,735	$5,249,673	$357,100	$8,247	$7,965,955
Nancy Valente	Chief Development Officer	$360,000	—	$1,063,743	$3,487,442	$153,000	$104,677	$5,168,862
John Desjarlais	Chief Scientific Officer	$518,900	—	$589,564	$1,874,883	$220,500	$9,247	$3,213,094
Allen S. Yang	Former Senior Vice President and Chief Medical Officer	$260,000	—	$471,639	$1,499,907	—	$712,818	$2,944,364
John Kuch	CFO	$468,000	—	$377,317	$1,199,929	$179,000	$9,247	$2,233,493
General Counsel	—	$457,600	—	$330,141	$1,049,931	$175,000	$9,247	$2,021,919
Celia E. Eckert	Senior Vice President, General Counsel and Corporate Secretary	$457,600	—	$330,141	$1,049,931	$175,000	$9,247	$2,021,919

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	CEO	$670,000	—	$1,493,825	$5,132,880	$402,000	$7,247	$7,705,952
John Desjarlais	Chief Scientific Officer	$485,000	—	$1,075,557	$1,168,043	$218,200	$8,247	$2,955,047
Allen S. Yang	Former Senior Vice President and Chief Medical Officer	$500,000	—	$995,883	$1,081,519	$225,000	$8,247	$2,810,649
John Kuch	CFO	$450,000	—	$697,124	$757,070	$202,500	$8,247	$2,114,941
Celia E. Eckert	Senior Vice President, General Counsel and Corporate Secretary	$440,000	—	$597,518	$648,915	$198,000	$8,247	$1,892,680
General Counsel	—	$440,000	—	$597,518	$648,915	$198,000	$8,247	$1,892,680

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	CEO	$625,000	—	$945,957	$3,340,406	$450,000	$8,932	$5,370,295
John Desjarlais	Chief Scientific Officer	$465,000	—	$448,103	$1,452,190	$251,100	$8,932	$2,625,325
Allen S. Yang	Former Senior Vice President and Chief Medical Officer	$480,000	—	$398,309	$1,290,835	$259,200	$8,932	$2,437,276
John Kuch	CFO	$415,000	—	$258,903	$839,034	$224,100	$8,932	$1,745,969
General Counsel	—	$400,000	—	$258,903	$839,034	$192,000	$8,932	$1,698,869

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	CEO	$600,000	—	$761,969	$2,747,024	$363,000	$8,932	$4,480,925
John Desjarlais	Chief Scientific Officer	$437,000	—	$293,264	$939,711	$192,000	$8,932	$1,870,907
John Kuch	CFO	$400,000	—	$218,762	$700,447	$176,000	$8,932	$1,504,141
General Counsel	—	$386,000	—	$101,585	$325,289	$170,000	$16,854	$999,728
Allen S. Yang	Former Senior Vice President and Chief Medical Officer	$465,000	—	—	—	$205,000	$8,932	$678,932

Key facts CIK 1326732 CUSIP 98401F105 13F (30d) 32 filings 32 filers Visit website Investor relations